Parkinson’s and the difficulty of treating neurological conditions
Neurological conditions such as Parkinson’s disease and Alzheimer’s disease have long evaded...
Axovant fails while Pfizer leaves – the grim outlook of Alzheimer’s research
In yet another setback to the treatment of Alzheimer’s disease, Axovant Sciences...
Immunotherapy: the future of Alzheimer’s research?
Alzheimer’s research may see a well needed boost in the form of...
Failed trials for Alzheimer’s may mean a key theory is wrong
A drug trial for a Merck & Co Inc. (MSD) medication verubecestat...
